These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17308999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH, Choi HS, Jeong SY, Sohn DK, Kim DW, Park JG.
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS, Choi YJ, Pyo HR, Kim H, Seong J, Chung HC, Rha SY, Kim NK.
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [Abstract] [Full Text] [Related]

  • 8. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients.
    Box B, Lindsey I, Wheeler JM, Warren BF, Cunningham C, George BD, Mortensen NJ, Jones AC.
    Dis Colon Rectum; 2005 Jun 01; 48(6):1153-60. PubMed ID: 15868236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01).
    Kim DY, Kim TH, Jung KH, Chang HJ, Lim SB, Choi HS, Jeong SY, Nam TK, Ryu SY, Lee DS, Choi SI, Kang JH, Yoon SC.
    Dis Colon Rectum; 2006 Nov 01; 49(11):1684-91. PubMed ID: 16988851
    [Abstract] [Full Text] [Related]

  • 13. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
    Kang SY, Han JH, Lee KJ, Choi JH, Park JI, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim HY.
    Clin Cancer Res; 2007 Jul 15; 13(14):4146-53. PubMed ID: 17634542
    [Abstract] [Full Text] [Related]

  • 14. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I.
    Orv Hetil; 2006 Oct 22; 147(42):2011-20. PubMed ID: 17165600
    [Abstract] [Full Text] [Related]

  • 15. Preoperative chemoradiotherapy in locally advanced rectal cancer: Ramathibodi experience.
    Sirachainan E, Sumboonnanonda K, Dangprasert S, Panvichian R, Sirisinha T, Dhanachai M, Pairachvet V, Kraiphibul P, Ratanatharathorn V.
    J Med Assoc Thai; 2005 Feb 22; 88(2):162-7. PubMed ID: 15962665
    [Abstract] [Full Text] [Related]

  • 16. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M.
    Ann Surg Oncol; 2005 Feb 22; 12(2):111-6. PubMed ID: 15827790
    [Abstract] [Full Text] [Related]

  • 17. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2005 Dec 01; 11(23):8341-7. PubMed ID: 16322294
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
    Unsal Kilic D, Uner A, Akyurek N, Erpolat P, Dursun A, Pak Y.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):196-203. PubMed ID: 17071013
    [Abstract] [Full Text] [Related]

  • 19. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y, Wexner SD, Berho M.
    Colorectal Dis; 2012 May 01; 14(5):555-61. PubMed ID: 21689364
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ.
    Dis Colon Rectum; 2004 Jun 01; 47(6):825-31. PubMed ID: 15108025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.